# Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

> **NCT00188812** · PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto**

## Conditions studied

- Dementia Associated With Cerebrovascular Disease

## Interventions

- **DRUG:** donepezil hcl

## Key facts

- **NCT ID:** NCT00188812
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188812, "Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00188812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*